| __timestamp | Rhythm Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 59644696 |
| Thursday, January 1, 2015 | 3425000 | 79541000 |
| Friday, January 1, 2016 | 6311000 | 98015000 |
| Sunday, January 1, 2017 | 9518000 | 103958000 |
| Monday, January 1, 2018 | 28080000 | 103654000 |
| Tuesday, January 1, 2019 | 36550000 | 128951000 |
| Wednesday, January 1, 2020 | 46125000 | 135799000 |
| Friday, January 1, 2021 | 68486000 | 149883000 |
| Saturday, January 1, 2022 | 92032000 | 220206000 |
| Sunday, January 1, 2023 | 117532000 | 265542000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. Rhythm Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have been navigating this financial landscape since 2014. Over the past decade, Travere Therapeutics has consistently reported higher SG&A expenses, peaking at approximately 265% more than Rhythm Pharmaceuticals in 2023. This trend suggests a more aggressive investment in administrative and sales functions. Meanwhile, Rhythm Pharmaceuticals has shown a steady increase in SG&A costs, with a notable 9-fold rise from 2014 to 2023. This indicates a strategic scaling of operations. The data highlights the contrasting approaches of these two companies in managing their operational costs, reflecting their unique business strategies and market positions.
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Incyte Corporation or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of Veracyte, Inc. and Travere Therapeutics, Inc.
HUTCHMED (China) Limited or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.